Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacterial Toxins | 15 | 2024 | 265 | 3.820 |
Why?
|
| Bacterial Proteins | 9 | 2024 | 474 | 1.880 |
Why?
|
| Antigens, Bacterial | 6 | 2020 | 159 | 1.130 |
Why?
|
| Bacillus anthracis | 9 | 2020 | 146 | 1.120 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 3 | 2018 | 26 | 1.100 |
Why?
|
| Macrophages | 8 | 2018 | 273 | 1.070 |
Why?
|
| Zinc Fingers | 4 | 2008 | 26 | 1.030 |
Why?
|
| Antibodies, Neutralizing | 4 | 2020 | 69 | 0.950 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2011 | 31 | 0.780 |
Why?
|
| Epitopes | 3 | 2020 | 171 | 0.750 |
Why?
|
| Leukocytes | 2 | 2018 | 67 | 0.720 |
Why?
|
| Anthrax | 4 | 2020 | 85 | 0.720 |
Why?
|
| Immunity, Innate | 2 | 2021 | 205 | 0.710 |
Why?
|
| Animals | 26 | 2024 | 9960 | 0.700 |
Why?
|
| Cyclic AMP | 3 | 2018 | 80 | 0.670 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 25 | 0.630 |
Why?
|
| Enterotoxins | 1 | 2017 | 21 | 0.590 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2017 | 6 | 0.590 |
Why?
|
| Peptide Fragments | 2 | 2017 | 197 | 0.570 |
Why?
|
| Repressor Proteins | 2 | 2019 | 114 | 0.560 |
Why?
|
| Sodium Selenite | 2 | 2008 | 4 | 0.530 |
Why?
|
| Cricetulus | 5 | 2020 | 56 | 0.500 |
Why?
|
| CHO Cells | 5 | 2020 | 96 | 0.490 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2015 | 12 | 0.490 |
Why?
|
| Mice | 13 | 2023 | 4406 | 0.480 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2013 | 6 | 0.440 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 25 | 0.430 |
Why?
|
| Cell Line | 6 | 2018 | 672 | 0.430 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 623 | 0.410 |
Why?
|
| Cytokines | 6 | 2022 | 438 | 0.410 |
Why?
|
| Signal Transduction | 6 | 2021 | 1344 | 0.400 |
Why?
|
| Receptors, Peptide | 2 | 2011 | 20 | 0.400 |
Why?
|
| Monocytes | 1 | 2013 | 132 | 0.400 |
Why?
|
| Sp1 Transcription Factor | 3 | 2008 | 17 | 0.380 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2011 | 13 | 0.370 |
Why?
|
| Transcription Factor TFIIIA | 3 | 2008 | 12 | 0.360 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 50 | 0.360 |
Why?
|
| Humans | 20 | 2024 | 26826 | 0.340 |
Why?
|
| Hydrocarbons | 2 | 2010 | 41 | 0.340 |
Why?
|
| Dendritic Cells | 1 | 2011 | 141 | 0.330 |
Why?
|
| Transcription Factors | 3 | 2008 | 509 | 0.330 |
Why?
|
| Azoles | 1 | 2008 | 4 | 0.320 |
Why?
|
| Organoselenium Compounds | 1 | 2008 | 8 | 0.320 |
Why?
|
| Histidine | 2 | 2005 | 50 | 0.310 |
Why?
|
| Cysteine | 2 | 2005 | 67 | 0.310 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 72 | 0.310 |
Why?
|
| Clostridium Infections | 2 | 2020 | 66 | 0.300 |
Why?
|
| Antibodies, Bacterial | 2 | 2020 | 100 | 0.300 |
Why?
|
| Cell Nucleus | 1 | 2008 | 135 | 0.300 |
Why?
|
| Amino Acid Sequence | 5 | 2024 | 674 | 0.290 |
Why?
|
| Spores, Bacterial | 3 | 2020 | 45 | 0.270 |
Why?
|
| Gold Sodium Thiomalate | 1 | 2005 | 3 | 0.260 |
Why?
|
| DNA | 2 | 2008 | 365 | 0.250 |
Why?
|
| HeLa Cells | 2 | 2023 | 206 | 0.250 |
Why?
|
| Heart | 1 | 2005 | 219 | 0.230 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 1036 | 0.230 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2024 | 152 | 0.220 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2023 | 7 | 0.220 |
Why?
|
| Liver | 2 | 2021 | 415 | 0.210 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 73 | 0.200 |
Why?
|
| Lymphatic Vessels | 1 | 2021 | 17 | 0.190 |
Why?
|
| Capillaries | 1 | 2021 | 32 | 0.190 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 36 | 0.190 |
Why?
|
| Anthrax Vaccines | 2 | 2020 | 34 | 0.190 |
Why?
|
| Bronchi | 1 | 2021 | 38 | 0.190 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 51 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 64 | 0.180 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 109 | 0.180 |
Why?
|
| RNA, Messenger | 1 | 2023 | 646 | 0.180 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2000 | 10 | 0.180 |
Why?
|
| Carbon Monoxide | 1 | 2000 | 47 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 324 | 0.180 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2020 | 9 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2021 | 970 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2021 | 324 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2023 | 465 | 0.160 |
Why?
|
| Bacterial Vaccines | 1 | 2019 | 28 | 0.160 |
Why?
|
| Virulence Factors | 2 | 2017 | 45 | 0.160 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 21 | 0.160 |
Why?
|
| Immunomodulation | 1 | 2018 | 19 | 0.160 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 275 | 0.150 |
Why?
|
| Amiloride | 1 | 2017 | 3 | 0.150 |
Why?
|
| Pinocytosis | 1 | 2017 | 17 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2009 | 560 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 152 | 0.140 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 3 | 2008 | 71 | 0.140 |
Why?
|
| Xenopus laevis | 2 | 2008 | 47 | 0.130 |
Why?
|
| beta Catenin | 2 | 2022 | 62 | 0.130 |
Why?
|
| Sequence Alignment | 1 | 2015 | 110 | 0.120 |
Why?
|
| Virulence | 3 | 2009 | 144 | 0.120 |
Why?
|
| Protein Binding | 2 | 2013 | 631 | 0.110 |
Why?
|
| Rats | 4 | 2010 | 1545 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 3 | 2009 | 264 | 0.110 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 8 | 0.110 |
Why?
|
| Bucladesine | 1 | 2013 | 11 | 0.110 |
Why?
|
| Transcription Factor HES-1 | 1 | 2013 | 6 | 0.110 |
Why?
|
| Immunoglobulin G | 3 | 2020 | 266 | 0.110 |
Why?
|
| Rats, Long-Evans | 2 | 2005 | 35 | 0.110 |
Why?
|
| Luciferases | 1 | 2013 | 49 | 0.110 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 1259 | 0.110 |
Why?
|
| Peptidoglycan | 1 | 2013 | 47 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 46 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2013 | 122 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 74 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2013 | 172 | 0.100 |
Why?
|
| Female | 8 | 2021 | 14462 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 152 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2009 | 503 | 0.100 |
Why?
|
| Hazardous Substances | 1 | 2011 | 6 | 0.100 |
Why?
|
| Gene Expression | 1 | 2013 | 406 | 0.100 |
Why?
|
| Male | 7 | 2021 | 12869 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 1475 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2011 | 63 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 481 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 89 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2023 | 240 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 140 | 0.090 |
Why?
|
| Molecular Weight | 2 | 2011 | 118 | 0.090 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2009 | 38 | 0.080 |
Why?
|
| Antigens, CD1d | 1 | 2009 | 45 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2009 | 75 | 0.080 |
Why?
|
| Neutralization Tests | 2 | 2020 | 32 | 0.080 |
Why?
|
| Isoindoles | 1 | 2008 | 5 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2009 | 54 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2008 | 40 | 0.080 |
Why?
|
| Ovary | 1 | 2008 | 69 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 110 | 0.080 |
Why?
|
| Middle Aged | 5 | 2020 | 6817 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2008 | 32 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 110 | 0.080 |
Why?
|
| Chemokines | 2 | 2022 | 73 | 0.070 |
Why?
|
| Transfection | 1 | 2008 | 313 | 0.070 |
Why?
|
| Adult | 5 | 2020 | 7382 | 0.070 |
Why?
|
| Alanine | 1 | 2007 | 40 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 247 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 400 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2005 | 43 | 0.060 |
Why?
|
| Xenopus | 1 | 2005 | 28 | 0.060 |
Why?
|
| Young Adult | 3 | 2020 | 2581 | 0.060 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2005 | 7 | 0.060 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2005 | 7 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 12 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 11 | 0.060 |
Why?
|
| Administration, Cutaneous | 1 | 2005 | 18 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2005 | 22 | 0.060 |
Why?
|
| Lead | 1 | 2005 | 8 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 43 | 0.060 |
Why?
|
| Cadmium | 1 | 2005 | 14 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 377 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 238 | 0.060 |
Why?
|
| Myocardium | 1 | 2005 | 171 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 261 | 0.060 |
Why?
|
| Zinc | 1 | 2005 | 57 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 139 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2004 | 44 | 0.060 |
Why?
|
| Binding Sites | 1 | 2005 | 338 | 0.060 |
Why?
|
| Thrombin | 1 | 2004 | 68 | 0.060 |
Why?
|
| Aged | 3 | 2021 | 5166 | 0.060 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2023 | 6 | 0.060 |
Why?
|
| Kidney | 1 | 2005 | 275 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 354 | 0.060 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 14 | 0.060 |
Why?
|
| Transcription Factor AP-2 | 1 | 2002 | 5 | 0.050 |
Why?
|
| RNA Polymerase III | 1 | 2002 | 5 | 0.050 |
Why?
|
| RNA Polymerase II | 1 | 2002 | 7 | 0.050 |
Why?
|
| Papio | 1 | 2023 | 78 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 28 | 0.050 |
Why?
|
| Calgranulin B | 1 | 2022 | 17 | 0.050 |
Why?
|
| Quinolones | 1 | 2022 | 22 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 283 | 0.050 |
Why?
|
| RNA | 1 | 2002 | 104 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2004 | 210 | 0.050 |
Why?
|
| Inflammation | 2 | 2021 | 601 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2008 | 507 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2021 | 12 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 20 | 0.050 |
Why?
|
| Cell Death | 1 | 2021 | 110 | 0.050 |
Why?
|
| Interferons | 1 | 2021 | 68 | 0.050 |
Why?
|
| Auditory Threshold | 1 | 2000 | 15 | 0.050 |
Why?
|
| Occupational Exposure | 1 | 2000 | 25 | 0.040 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 15 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2021 | 121 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 44 | 0.040 |
Why?
|
| Turkey | 1 | 2020 | 9 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 349 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2020 | 58 | 0.040 |
Why?
|
| Movement | 1 | 2020 | 92 | 0.040 |
Why?
|
| Action Potentials | 1 | 2000 | 194 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 46 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 276 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2020 | 113 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2019 | 65 | 0.040 |
Why?
|
| Glycosylation | 1 | 2019 | 69 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 48 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 439 | 0.040 |
Why?
|
| Brain | 1 | 2004 | 699 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 250 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 316 | 0.040 |
Why?
|
| Time Factors | 1 | 2002 | 1562 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 460 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 665 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 700 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 167 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2009 | 165 | 0.040 |
Why?
|
| Mutation | 1 | 2020 | 817 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 1927 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 945 | 0.030 |
Why?
|
| Chlorides | 1 | 2011 | 13 | 0.020 |
Why?
|
| Sulfur Compounds | 1 | 2011 | 3 | 0.020 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2011 | 5 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 25 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 42 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 87 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 36 | 0.020 |
Why?
|
| Inhalation Exposure | 1 | 2010 | 15 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 408 | 0.020 |
Why?
|
| Myelin Basic Protein | 1 | 2009 | 4 | 0.020 |
Why?
|
| Phosphopeptides | 1 | 2009 | 11 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 330 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 129 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2009 | 31 | 0.020 |
Why?
|
| Gene Order | 1 | 2008 | 9 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2008 | 32 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2008 | 37 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 545 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 186 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 78 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 282 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2008 | 106 | 0.020 |
Why?
|
| Complement C3c | 1 | 2008 | 3 | 0.020 |
Why?
|
| alpha-Macroglobulins | 1 | 2008 | 4 | 0.020 |
Why?
|
| Ceruloplasmin | 1 | 2008 | 8 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 20 | 0.020 |
Why?
|
| Trypsin | 1 | 2008 | 24 | 0.020 |
Why?
|
| Alanine Racemase | 1 | 2007 | 2 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 30 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2007 | 45 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 394 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 456 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 284 | 0.020 |
Why?
|
| Nitroprusside | 1 | 2004 | 8 | 0.010 |
Why?
|
| Maleimides | 1 | 2004 | 6 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 23 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2004 | 72 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2004 | 102 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 253 | 0.010 |
Why?
|
| Microcirculation | 1 | 2004 | 111 | 0.010 |
Why?
|
| Indoles | 1 | 2004 | 98 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 243 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2004 | 189 | 0.010 |
Why?
|
| Apoptosis | 1 | 2004 | 739 | 0.010 |
Why?
|